淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7066人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302046, encodeId=db831302046fd, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Med：B淋巴细胞可能分泌防止早产的分子, objectType=article, longId=85831, objectId=62d3858313c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62d3858313c, replyNumber=0, likeNumber=61, createdTime=2016-12-30, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62d3858313c, moduleTitle=Nat Med：B淋巴细胞可能分泌防止早产的分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62d3858313c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302045, encodeId=214713020456d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Med：B淋巴细胞一直被忽视的功能：预防和治疗早产, objectType=article, longId=85450, objectId=84df854504b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84df854504b, replyNumber=0, likeNumber=63, createdTime=2016-12-26, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84df854504b, moduleTitle=Nat Med：B淋巴细胞一直被忽视的功能：预防和治疗早产, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84df854504b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302044, encodeId=36bb1302044f8, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研, objectType=article, longId=83264, objectId=96fb832645e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fb832645e, replyNumber=0, likeNumber=53, createdTime=2016-11-30, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fb832645e, moduleTitle=成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96fb832645e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302043, encodeId=e8ac130204390, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JCO：慢性淋巴细胞性白血病患者口服靶向治疗药物的经济负担研究, objectType=article, longId=83024, objectId=ed04830241f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed04830241f, replyNumber=0, likeNumber=73, createdTime=2016-11-26, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed04830241f, moduleTitle=JCO：慢性淋巴细胞性白血病患者口服靶向治疗药物的经济负担研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed04830241f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302042, encodeId=66d913020428c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=中国成人急性淋巴细胞白血病诊断与治疗指南（2016年版）, objectType=article, longId=81798, objectId=a8ee81e9863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8ee81e9863, replyNumber=0, likeNumber=62, createdTime=2016-11-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8ee81e9863, moduleTitle=中国成人急性淋巴细胞白血病诊断与治疗指南（2016年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8ee81e9863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302041, encodeId=4c9a1302041e9, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2016NCCN临床实践指南：急性淋巴细胞白血病（2016.V2）发布, objectType=article, longId=80725, objectId=9ddd80e259b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ddd80e259b, replyNumber=0, likeNumber=37, createdTime=2016-10-24, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ddd80e259b, moduleTitle=2016NCCN临床实践指南：急性淋巴细胞白血病（2016.V2）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ddd80e259b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302040, encodeId=1491130204071, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2016CCO实践指南：利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病发布, objectType=article, longId=80524, objectId=8e848052465, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e848052465, replyNumber=0, likeNumber=0, createdTime=2016-10-22, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e848052465, moduleTitle=2016CCO实践指南：利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e848052465)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302039, encodeId=f7991302039ad, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2017NCCN临床实践指南——慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2017.V1）发布, objectType=article, longId=80032, objectId=b31a800321e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b31a800321e, replyNumber=0, likeNumber=28, createdTime=2016-10-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b31a800321e, moduleTitle=2017NCCN临床实践指南——慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2017.V1）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b31a800321e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302038, encodeId=232e130203802, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布, objectType=article, longId=79984, objectId=9181e99846e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181e99846e, replyNumber=0, likeNumber=27, createdTime=2016-10-14, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181e99846e, moduleTitle=2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9181e99846e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302037, encodeId=aa88130203e1b, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2015ESMO恶性淋巴瘤共识会议建议——成熟的B细胞淋巴瘤和慢性淋巴细胞白血病的预测工具发布, objectType=article, longId=79904, objectId=d18ae9904b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18ae9904b4, replyNumber=0, likeNumber=25, createdTime=2016-10-14, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18ae9904b4, moduleTitle=2015ESMO恶性淋巴瘤共识会议建议——成熟的B细胞淋巴瘤和慢性淋巴细胞白血病的预测工具发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d18ae9904b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302036, encodeId=5eb4130203639, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Annals of Surgery：中性粒细胞/淋巴细胞比值预测IPMN相关侵袭癌, objectType=article, longId=78716, objectId=1cb9e871609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cb9e871609, replyNumber=0, likeNumber=77, createdTime=2016-09-29, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cb9e871609, moduleTitle=Annals of Surgery：中性粒细胞/淋巴细胞比值预测IPMN相关侵袭癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cb9e871609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302035, encodeId=93ff1302035d7, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期, objectType=article, longId=77709, objectId=5f4ae770963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f4ae770963, replyNumber=0, likeNumber=63, createdTime=2016-09-19, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f4ae770963, moduleTitle=NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f4ae770963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302034, encodeId=815a130203454, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2015培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识发布, objectType=article, longId=76926, objectId=fc0ce69267e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc0ce69267e, replyNumber=0, likeNumber=22, createdTime=2016-09-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc0ce69267e, moduleTitle=2015培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc0ce69267e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302032, encodeId=36e61302032ce, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=第4个适应症！诺华抗癌药Arzerra获FDA批准治疗复发性慢性淋巴细胞白血病（CLL）, objectType=article, longId=76568, objectId=80e0e6568b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80e0e6568b4, replyNumber=0, likeNumber=61, createdTime=2016-09-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80e0e6568b4, moduleTitle=第4个适应症！诺华抗癌药Arzerra获FDA批准治疗复发性慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80e0e6568b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302033, encodeId=f73d1302033bc, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=喜讯！FDA加速批准安进BiTE免疫疗法Blincyto治疗儿科Ph-急性淋巴细胞白血病（ALL）, objectType=article, longId=76569, objectId=1570e65698b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1570e65698b, replyNumber=0, likeNumber=76, createdTime=2016-09-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1570e65698b, moduleTitle=喜讯！FDA加速批准安进BiTE免疫疗法Blincyto治疗儿科Ph-急性淋巴细胞白血病（ALL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1570e65698b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302031, encodeId=dcbe130203183, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Immunity：NK B 细胞调节天然淋巴细胞抗感染机制, objectType=article, longId=73349, objectId=c71ae334966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c71ae334966, replyNumber=0, likeNumber=79, createdTime=2016-07-22, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c71ae334966, moduleTitle=Immunity：NK B 细胞调节天然淋巴细胞抗感染机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c71ae334966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302030, encodeId=24ac13020303f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2016 NCCN临床实践指南：急性淋巴细胞白血病（Version1.2016）, objectType=article, longId=72096, objectId=7b58e20966a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b58e20966a, replyNumber=0, likeNumber=51, createdTime=2016-07-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b58e20966a, moduleTitle=2016 NCCN临床实践指南：急性淋巴细胞白血病（Version1.2016）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b58e20966a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302029, encodeId=cc93130202984, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Stroke：脑出血后淋巴细胞减少症是不良预后的独立预测因子, objectType=article, longId=71902, objectId=49ece1902f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49ece1902f6, replyNumber=0, likeNumber=62, createdTime=2016-07-02, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49ece1902f6, moduleTitle=Stroke：脑出血后淋巴细胞减少症是不良预后的独立预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49ece1902f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302028, encodeId=0d0313020286e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=EHA 2016：辉瑞ADC药物inotuzumab ozogamicin治疗CD22阳性急性淋巴细胞白血病（ALL）表现出强劲疗效, objectType=article, longId=70650, objectId=3744e0650f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3744e0650f8, replyNumber=0, likeNumber=56, createdTime=2016-06-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3744e0650f8, moduleTitle=EHA 2016：辉瑞ADC药物inotuzumab ozogamicin治疗CD22阳性急性淋巴细胞白血病（ALL）表现出强劲疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3744e0650f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302027, encodeId=0269130202e7e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=第5个适应症！欧盟批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, objectType=article, longId=70030, objectId=0f9ae003001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f9ae003001, replyNumber=0, likeNumber=73, createdTime=2016-06-07, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f9ae003001, moduleTitle=第5个适应症！欧盟批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f9ae003001)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Med：B淋巴细胞可能分泌防止早产的分子

2016-12-30

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Med：B淋巴细胞一直被忽视的功能：预防和治疗早产

2016-12-26

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

成年费城染色体阳性急性淋巴细胞白血病患者的疾病流行率与治疗效果调研

2016-11-30

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JCO：慢性淋巴细胞性白血病患者口服靶向治疗药物的经济负担研究

2016-11-26

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

中国成人急性淋巴细胞白血病诊断与治疗指南（2016年版）

2016-11-06

heli0118 (审核中...)

前往app查看评论内容

#淋巴细胞#

2016NCCN临床实践指南：急性淋巴细胞白血病（2016.V2）发布

2016-10-24

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2016CCO实践指南：利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病发布

2016-10-22

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2017NCCN临床实践指南——慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2017.V1）发布

2016-10-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2015NICE技术评估指南——Idelalisib治疗慢性淋巴细胞白血病（TA359）发布

2016-10-14

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2015ESMO恶性淋巴瘤共识会议建议——成熟的B细胞淋巴瘤和慢性淋巴细胞白血病的预测工具发布

2016-10-14

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Annals of Surgery：中性粒细胞/淋巴细胞比值预测IPMN相关侵袭癌

2016-09-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期

2016-09-19

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2015培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识发布

2016-09-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

第4个适应症！诺华抗癌药Arzerra获FDA批准治疗复发性慢性淋巴细胞白血病（CLL）

2016-09-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

喜讯！FDA加速批准安进BiTE免疫疗法Blincyto治疗儿科Ph-急性淋巴细胞白血病（ALL）

2016-09-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Immunity：NK B 细胞调节天然淋巴细胞抗感染机制

2016-07-22

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2016 NCCN临床实践指南：急性淋巴细胞白血病（Version1.2016）

2016-07-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Stroke：脑出血后淋巴细胞减少症是不良预后的独立预测因子

2016-07-02

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

EHA 2016：辉瑞ADC药物inotuzumab ozogamicin治疗CD22阳性急性淋巴细胞白血病（ALL）表现出强劲疗效

2016-06-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

第5个适应症！欧盟批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）

2016-06-07

科室
- - 订阅+
  - 更多科室
工具
服务